Russell Investments Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-368
| Closed | -$2.19K | – | 3845 |
|
|
2025
Q1 | $2.19K | Sell |
368
-351
| -49% | -$3.06K | ﹤0.01% | 3503 |
|
|
2024
Q4 | $9.57K | Hold |
719
| – | – | ﹤0.01% | 3143 |
|
|
2024
Q3 | $5.84K | Buy |
719
+717
| +35,850% | +$6.14K | ﹤0.01% | 3187 |
|
|
2024
Q2 | $17 | Buy |
+2
| New | +$30 | ﹤0.01% | 3570 |
|
|
2023
Q4 | – | Sell |
-6
| Closed | -$226 | – | 3213 |
|
|
2023
Q3 | $226 | Sell |
6
-222
| -97% | -$9.88K | ﹤0.01% | 3479 |
|
|
2023
Q2 | $9.19K | Hold |
228
| – | – | ﹤0.01% | 2978 |
|
|
2023
Q1 | $16.6K | Buy |
+228
| New | +$22.1K | ﹤0.01% | 2838 |
|
|
2021
Q3 | – | Sell |
-836
| Closed | -$324K | – | 3041 |
|
|
2021
Q2 | $324K | Sell |
836
-78
| -9% | -$27.8K | ﹤0.01% | 2749 |
|
|
2021
Q1 | $327K | Buy |
+914
| New | +$404K | ﹤0.01% | 2679 |
|
|
2020
Q4 | – | Sell |
-1,017
| Closed | -$328K | – | 3038 |
|
|
2020
Q3 | $328K | Sell |
1,017
-57
| -5% | -$19.4K | ﹤0.01% | 2578 |
|
|
2020
Q2 | $390K | Buy |
+1,074
| New | +$271K | ﹤0.01% | 2479 |
|
|
2020
Q1 | – | Sell |
-2,021
| Closed | -$830K | – | 3029 |
|
|
2019
Q4 | $830K | Hold |
2,021
| – | – | ﹤0.01% | 2200 |
|
|
2019
Q3 | $712K | Buy |
+2,021
| New | +$754K | ﹤0.01% | 2160 |
|
|
2017
Q4 | – | Sell |
-410
| Closed | -$170K | – | 2951 |
|
|
2017
Q3 | $170K | Buy |
+410
| New | +$155K | ﹤0.01% | 2697 |
|
|
2017
Q2 | – | Sell |
-61
| Closed | -$31K | – | 2962 |
|
|
2017
Q1 | $31K | Sell |
61
-220
| -78% | -$91.1K | ﹤0.01% | 2940 |
|
|
2016
Q4 | $101K | Buy |
+281
| New | +$119K | ﹤0.01% | 2877 |
|
Other funds holding ATRA
EC
RG
VPC
SCA
